ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.836,14
0,07%
S&P 500
5.307,56
-0,01%
US Dollar vs BRL
5,0887
-0,31%
Bitcoin
70.601,16
-1,19%
Brent Oil
82,85
-0,81%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. TherapeuticsMD Inc (TXMD)

  7. TherapeuticsMD Inc (TXMD) Notícias

TXMD

TherapeuticsMD (TXMD)

TherapeuticsMD Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TXMD
DataHoraFonteTítuloCódigoCompanhia
10/05/202417:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TXMDTherapeuticsMD Inc
10/05/202417:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXMDTherapeuticsMD Inc
10/05/202417:05Business WireTherapeuticsMD Announces First Quarter 2024 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/03/202417:00Business WireTherapeuticsMD Announces Full Year 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
07/12/202318:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
06/12/202313:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXMDTherapeuticsMD Inc
17/11/202311:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TXMDTherapeuticsMD Inc
14/11/202318:05Business WireTherapeuticsMD Announces Third Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
21/08/202317:20Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TXMDTherapeuticsMD Inc
14/08/202307:50Business WireTherapeuticsMD Announces Second Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
29/06/202318:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TXMDTherapeuticsMD Inc
28/06/202308:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202318:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TXMDTherapeuticsMD Inc
17/05/202318:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202317:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TXMDTherapeuticsMD Inc
15/05/202317:05Business WireTherapeuticsMD Announces First Quarter 2023 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
04/05/202317:40Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TXMDTherapeuticsMD Inc
01/05/202318:03Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202317:48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TXMDTherapeuticsMD Inc
07/04/202317:01Business WireTherapeuticsMD Announces Full Year 2022 Financial Results and Provides Update on Business Model TransitionNASDAQ:TXMDTherapeuticsMD Inc
31/03/202318:04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:TXMDTherapeuticsMD Inc
13/02/202319:25Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:TXMDTherapeuticsMD Inc
06/01/202319:31Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:TXMDTherapeuticsMD Inc
03/01/202308:50Business WireTherapeuticsMD Completes Transaction to License Its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
05/12/202204:39TipRanksTherapeuticsMD Inks Licensing Deal with Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
04/12/202220:00Business WireTherapeuticsMD Announces Definitive Agreements to License its Products to Mayne PharmaNASDAQ:TXMDTherapeuticsMD Inc
14/11/202219:23Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:TXMDTherapeuticsMD Inc
14/11/202218:05Business WireTherapeuticsMD Announces Third Quarter 2022 Financial ResultsNASDAQ:TXMDTherapeuticsMD Inc
31/10/202207:50Business WireTherapeuticsMD Announces Additional $7 Million Private PlacementNASDAQ:TXMDTherapeuticsMD Inc
03/10/202207:50Business WireTherapeuticsMD Announces $7 Million Private PlacementNASDAQ:TXMDTherapeuticsMD Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TXMD

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
HAGA3
HAGA ON
BOV
PRIO3
PETRORIO ON
BOV
SGPS3
SPRINGS ON
BOV
INBR32
Inter &
BOV
COGN3
COGNA ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
GOLL4
GOL PN
BOV
LUPA3
LUPATECH ON
BOV
AZEV4
AZEVEDO PN
BOV
CASH3
Meliuz S.A ON
BOV
JHSF3
JHSF PART ON
BOV
LWSA3
LOCAWEB ON
BOV
CMIG4
CEMIG PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados